Stock News
PharmaTher’s Ketamine NDA Update: A Peek into the FDA’s Mysterious Drug Approval Process
Exciting News from PharmaTher: A Fresh Lease of Life for Ketamine Therapy PharmaTher, a leading biotech company, has recently announced some promising updates regarding the timeline for the Food and Drug Administration (FDA) approval of its ketamine therapy. Here’s what you need to know: What’s the Latest from PharmaTher? PharmaTher has shared that they are…
Merck’s Surprising Securities Saga: A Playful Look at the Lawsuit Against Merck & Co. Inc. or Merck’s Unexpected Legal Lemon: A Quirky Take on the Securities Lawsuit Against Merck & Co. Inc.
Merck & Co., Inc. (MRK) Investors: Understanding Your Potential Recovery Options If you’re among the many investors who have seen their Merck & Co., Inc. (MRK) stocks take a hit and are now considering legal action, you’re not alone. In the bustling financial world of New York City, news of a potential securities lawsuit against…
HII to Present at Citi’s 2025 Global Industrial Tech and Mobility Conference on February 18
HII to Participate in Citi’s Global Industrial Tech and Mobility Conference On February 18, 2025, Huntington Ingalls Industries (HII) (NYSE: HII) is set to participate in Citi’s Global Industrial Tech and Mobility Conference. This event, which brings together industry leaders, investors, and analysts, provides a platform for companies to discuss their business strategies, financial performance,…
Replimune’s Q3 2025 Financial Report: A Corporate Update on Their Latest Earnings and Progress
Replimune’s Oncolytic Immunotherapies: A New Frontier in Cancer Treatment In a recent press release, Replimune Group, Inc. announced significant developments in their oncology pipeline. The U.S. Food and Drug Administration (FDA) accepted the Biologics License Application (BLA) for RP1 (vusolimogene oderparepvec) in combination with nivolumab for the treatment of advanced melanoma. This application will undergo…
Homerun Resources Completes Acquisition of Guidoni-Belmonte Silica Mineral Rights
Homerun Resources Inc. Announces Assignment of Exploitation Rights in Brazil Vancouver, British Columbia – Homerun Resources Inc. (TSXV: HMR) (OTCQB: HMRFF) (“Homerun” or the “Company”), a mineral exploration company, is thrilled to share the news of a significant development in its operations. The Company has recently executed a definitive agreement with Guidoni Brasil S.A. (“Guidoni”)…
Guanajuato Silver Advances to Tier 1 Status on TSX Venture Exchange: A Major Milestone for the Metals and Mining Industry
Guanajuato Silver Company Ltd. Graduates to Tier 1 Issuer Status on TSX Venture Exchange VANCOUVER, BC, February 12, 2025 – Guanajuato Silver Company Ltd. (GSVR on TSXV, GSVRF on OTCQX) is thrilled to announce that it has received approval from the TSX Venture Exchange (TSXV) for the graduation of the Company from Tier 2 Issuer…
New Study Published in Nature Communications: Inno3107 Shows Promise as Treatment for Recurrent Respiratory Papillomatosis in Phase 12 Clinical Trials
Innovative DNA Medicine: INO-3107 and its Impact on Recurrent Respiratory Papillomatosis INOVIO, a leading biotechnology company, recently announced the publication of peer-reviewed data from its Phase 1/2 clinical trial involving INO-3107, a DNA medicine being developed as a potential treatment for Recurrent Respiratory Papillomatosis (RRP). This condition, characterized by the growth of non-cancerous papillomas in…
ISPIRE Technology’s Exciting Participation in Webull’s Corporate Webinar Series on February 18, 2025: A Can’t-Miss Event!
Ispire Technology’s Co-CEO to Present at Webull Consumer Webinar Los Angeles, CA – In an exciting development for investors and technology enthusiasts, Ispire Technology Inc. (NASDAQ: ISPR), a leading innovator in the vaping industry and precision dosing, announced that Michael Wang, Co-Chief Executive Officer, will present at the Webull Consumer Webinar Series: Consumer. This event…